P-Cure
Jerusalem
About P-Cure
P-Cure is a biotech company that develops a patient-centric proton therapy solution with clinical benefits and financial advantages. P-Cure provides a compact 360-gantry-less adaptive proton therapy system that fits any radiation oncology department's existing infrastructure. P-Cure's integrated solution for simulating, planning, positioning, and treating patients in the seated position will be optimal for delivering the maximum treatment dose to the tumor site while sparing healthy tissues and organs from treatment-related side effects.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Last round: Corporate Round (Jul 2019)
- Website: p-cure.com
- Phone: 972-8-637-3030
Industries & Categories
Biotechnology, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/p-cure-13662 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.